17(E)-Picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: Antiproliferative activity and molecular docking studies

被引：28
作者：
Ajdukovic, Jovana J. [1 ]
Djurendic, Evgenija A. [1 ]
Petri, Edward T. [3 ]
Klisuric, Olivera R. [2 ]
Celic, Andjelka S. [3 ]
Sakac, Marija N. [1 ]
Jakimov, Dimitar S. [4 ]
Gasi, Katarina M. Penov [1 ]
机构：
[1] Univ Novi Sad, Fac Sci, Dept Chem Biochem & Environm Protect, Novi Sad 21000, Serbia
[2] Univ Novi Sad, Fac Sci, Dept Phys, Novi Sad 21000, Serbia
[3] Univ Novi Sad, Fac Sci, Dept Biol & Ecol, Novi Sad 21000, Serbia
[4] Oncol Inst Vojvodina, Novi Sad 21204, Serbia
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 23期
关键词：
Androstane; 17 alpha-Picolyl and 17(E)-picolinylidene derivatives; Synthesis; Antiproliferative activity; Antitumor; Virtual screening; Molecular docking; BIOLOGICAL EVALUATION; ANTITUMOR-ACTIVITY; 17-PICOLYL; PHARMACOKINETICS; DETERMINANTS; INDUCTION; ESTROGEN; DESIGN;
D O I：
10.1016/j.bmc.2013.09.063
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We report a rapid and efficient synthesis of A-ring modified 17 alpha-picolyl and 17(E)-picolinylidene androstane derivatives from dehydroepiandrosterone. Compounds were validated spectroscopically and structurally characterized by X-ray crystallography. Virtual screening by molecular docking against clinical targets of steroidal anticancer drugs (ER alpha, AR, Aromatase and CYP17A1) suggests that 17(E)-picolinylidene, but not 17 alpha-picolyl androstanes could specifically interact with CYP17A1 (17 alpha-hydroxylase) with similar geometry and affinity as Abiraterone, a 17-pyridinyl androstane drug clinically used in the treatment of prostate cancer. In addition, several 17(E)-picolinylidene androstanes demonstrated selective antiproliferative activity against PC3 prostate cancer cells, which correlates with Abiraterone antiproliferative activity and predicted CYP17A1 binding affinities. Based on these preliminary results, 17(E)-picolinylidene androstane derivatives could be a promising starting point for the development of new compounds for the treatment of prostate cancer. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码：7257 / 7266
页数：10
相关论文
共 37 条
  • [1] Agilent, 2010, AG TECHN YARNT OXF C
  • [2] SIR97:: a new tool for crystal structure determination and refinement
    Altomare, A
    Burla, MC
    Camalli, M
    Cascarano, GL
    Giacovazzo, C
    Guagliardi, A
    Moliterni, AGG
    Polidori, G
    Spagna, R
    [J]. JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1999, 32 : 115 - 119
  • [3] 17α-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response
    Bruno, Robert D.
    Gover, Tony D.
    Burger, Angelika M.
    Brodie, Angela M.
    Njar, Vincent C. O.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2828 - 2836
  • [4] David-Beabes GL, 2000, INT J ONCOL, V17, P1077
  • [5] Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity
    De Jesus-Tran, KP
    Cote, PL
    Cantin, L
    Blanchet, J
    Labrie, F
    Breton, R
    [J]. PROTEIN SCIENCE, 2006, 15 (05) : 987 - 999
  • [6] Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001
    DeVore, Natasha M.
    Scott, Emily E.
    [J]. NATURE, 2012, 482 (7383) : 116 - U149
  • [7] Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity
    Djurendic, Evgenija
    Daljev, Jouana
    Sakac, Marija
    Canadi, Janos
    Santa, Suzana Jovanovic
    Andric, Silvana
    Klisuric, Olivera
    Kojic, Vesna
    Bogdanovic, Gordana
    Djurendic-Brenesel, Maja
    Novakovic, Sladjana
    Gasi, Katarina Penov
    [J]. STEROIDS, 2008, 73 (01) : 129 - 138
  • [8] Synthesis and cytotoxic activity of some 17-picolyl and 17-picolinylidene androstane derivatives
    Djurendic, Evgenija A.
    Ajdukovic, Jovana J.
    Sakac, Marija N.
    Csanadi, Janos J.
    Kojic, Vesna V.
    Bogdanovic, Gordana M.
    Gasi, Katarina M. Penov
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 54 : 784 - 792
  • [9] Farrugia L. J., 1999, Journal of Applied Crystallography, V32, P837, DOI [DOI 10.1107/S0021889812029111, 10.1107/S0021889899006020, DOI 10.1107/S0021889899006020]
  • [10] Gasi K.M, 2010, ACTA PERIOD TECHNOL, V41, P169
1234